UPDATED Apr 19, 2024
Over $1bn in market cap, profitable and undervalued based on cash flows.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
MSFT | US$404.33 | -5.5% | 41.3% | US$3.0t | US$471.24 | PE36.4x | E12.6% | 0.7% | Software | ||
GOOGL | US$154.09 | -2.3% | 46.2% | US$1.9t | US$166.60 | PE26x | E11.8% | n/a | Media | ||
AMZN | US$174.63 | -6.2% | 63.3% | US$1.9t | US$209.61 | PE59.7x | E21.5% | n/a | Retail | ||
META | US$481.07 | -6.0% | 126.0% | US$1.3t | US$539.79 | PE31.2x | E14.4% | 0.4% | Media | ||
LLY | US$726.31 | -3.4% | 88.5% | US$654.2b | US$813.32 | PE124.8x | E27.2% | 0.7% | Pharmaceuticals & Biotech | ||
2330 | NT$752.00 | -8.1% | 47.2% | NT$20.9t | NT$889.31 | PE22.8x | E16.0% | 1.9% | Semiconductors | ||
AVGO | US$1,258.99 | -8.9% | 98.9% | US$583.4b | US$1,500.96 | PE50.4x | E23.4% | 1.7% | Semiconductors | ||
NOVO B | kr.866.20 | -1.6% | 48.8% | kr.3.9t | kr.904.20 | PE46.2x | E14.8% | 1.1% | Pharmaceuticals & Biotech | ||
JPM | US$185.80 | 1.6% | 32.2% | US$520.6b | US$205.38 | PB1.7x | E-1.6% | 2.5% | Banks | ||
WMT | US$59.53 | -1.0% | 17.7% | US$477.5b | US$65.08 | PE30.9x | E10.7% | 1.4% | Consumer Retailing | ||
XOM | US$119.88 | -0.4% | 3.3% | US$469.1b | US$129.77 | PE13.2x | E-0.6% | 3.2% | Energy | ||
UNH | US$501.13 | 14.1% | 3.6% | US$462.0b | US$568.86 | PE30.1x | E19.7% | 1.5% | Healthcare | ||
A005930 | ₩77,500.00 | -7.4% | 18.0% | ₩529.8t | ₩101,991.89 | PE36.4x | E27.4% | 1.9% | Tech | ||
PG | US$158.14 | 1.8% | 1.3% | US$370.1b | US$169.71 | PE25x | E7.2% | 2.4% | Household | ||
700 | HK$304.40 | -3.4% | -14.7% | HK$2.8t | HK$418.02 | PE22.7x | E15.0% | 1.1% | Media | ||
JNJ | US$147.91 | 0.3% | -9.1% | US$356.4b | US$172.53 | PE18.6x | E4.9% | 3.2% | Pharmaceuticals & Biotech | ||
HD | US$332.89 | -4.2% | 11.5% | US$329.9b | US$384.83 | PE21.8x | E4.2% | 2.7% | Retail | ||
ORCL | US$114.88 | -5.1% | 20.7% | US$318.8b | US$137.02 | PE29.7x | E14.7% | 1.4% | Software | ||
MRK | US$125.78 | 0.03% | 9.0% | US$317.2b | US$137.66 | PE872.9x | E25.9% | 2.4% | Pharmaceuticals & Biotech | ||
COST | US$709.51 | -3.0% | 40.1% | US$314.7b | US$768.10 | PE46.3x | E7.5% | 0.6% | Consumer Retailing | ||
ABBV | US$166.41 | 2.5% | 2.5% | US$291.6b | US$184.14 | PE61.1x | E23.4% | 3.7% | Pharmaceuticals & Biotech | ||
CVX | US$160.00 | 0.7% | -5.4% | US$291.1b | US$181.53 | PE13.8x | E2.3% | 4.1% | Energy | ||
600519 | CN¥1,670.78 | 1.4% | -4.1% | CN¥2.1t | CN¥2,154.31 | PE28.1x | E12.8% | 3.0% | Food, Beverage & Tobacco | ||
BAC | US$36.97 | 3.3% | 23.8% | US$281.4b | US$39.52 | PB1.1x | E6.2% | 2.6% | Banks |